CoreFirst Bank & Trust
- SEC CIK
- 0001845199
- Latest filing
- Aug 5, 2026
GILD holding history
Gilead Sciences, Inc. in every 13F filed by CoreFirst Bank & Trust, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GILD overviewAll 13F holders of GILDFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −900−100.0% | Sold out | Holders |
| Q3 2025 | 900 | $99.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 900 | $99.8K | 0.1% | +900 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −900−100.0% | Sold out | Holders |
| Q4 2024 | 900 | $83.1K | <0.1% | −330−26.8% | Reduced | Holders |
| Q3 2024 | 1,230 | $103.1K | 0.1% | +1,230 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −1,590−100.0% | Sold out | Holders |
| Q1 2024 | 1,590 | $116.5K | 0.1% | −100−5.9% | Reduced | Holders |
| Q4 2023 | 1,690 | $136.9K | 0.1% | −230−12.0% | Reduced | Holders |
| Q3 2023 | 1,920 | $143.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,920 | $148.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,920 | $159.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,920 | $164.8K | 0.1% | −72−3.6% | Reduced | Holders |
| Q3 2022 | 1,992 | $123.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,992 | $123.0K | 0.1% | −877−30.6% | Reduced | Holders |
| Q1 2022 | 2,869 | $171.0K | 0.1% | −330−10.3% | Reduced | Holders |
| Q4 2021 | 3,199 | $232.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 3,199 | $223.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2021 | 3,199 | $220.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 3,199 | $207.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.